Study of Fluoxetine in Autism

Clinical trial NCT00515320 · COMPLETED

Trial details

NCT number: NCT00515320
Sponsor: Neuropharm
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Autistic Disorder

Start date: 2007-08-01
Primary completion: 2009-01-01
Enrollment: 158

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.